2014
$135M
from 10 investors over 10 rounds
Amylyx Pharmaceuticals raised $135M on July 20, 2021
Investors: Woodline Partners LP, Marshall Wace, Morningside Venture Capital 晨兴资本, Viking Global Investors, Polaris Founders Capital and Perceptive Advisors
Amylyx Pharmaceuticals raised $5M on August 22, 2016
Investors: Lysosomal Therapeutics Inc. and ALS Investment Fund
Amylyx Pharmaceuticals raised $3M on July 20, 2016
Investors: ALS Finding a Cure® and The ALS Association